COMPANY - Insmed, Inc.,INSM
NEWS - Insmed Inc., a biopharmaceutical company, today announced that it has been added to the Russell 3000 Index following Russell Investments' reconstitution of its comprehensive set of
ABOUT - Insmed Incorporated, a development stage company, engages in the development of recombinant protein drug. The company?s primary product includes IPLEX, a complex of recombinant human IGF-1 and its binding protein IGFBP-3 for use in the treatment of several serious medical conditions, as well as conducting a phase III enabling clinical trial for investigating IPLEX as a treatment for myotonic muscular dystrophy.
After Hours: 0.00 N/A (N/A) 8:00PM ET
Last Trade: 0.8901
Day's Range: N/A - N/A
52wk Range: 0.32 - 2.57
Volume: 0
---
WhisperFromWallStreet is a news letter focusing on sending specific alerts to our subscribers. These alerts represent which stocks we believe are going to run. Additionally we spend time teaching how to become a better trader. If you like more information or to Sign Up for free alerts, visit us at WhisperfromWallStreet.com
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT INFORMATION: Nothing in this press release should be interpreted as a solicitation to buy any stock or security represented herein. WhisperfromWallStreet, nor any of its affiliates are registered investment advisors or broker dealers. Information presented here is based on our opinion only.
